Invesaro

Stocks CHRW Financial statements

Financial statements

C. H. ROBINSON WORLDWIDE, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data C. H. ROBINSON WORLDWIDE, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue13,14414,86916,63115,31016,20723,10224,69717,59617,72516,233
Cost of revenue1,3171,244
Gross profit11,82713,625
Operating income8387759127906731,0821,267515669795
Pre-tax income8127288807426281,0221,167409579722
Income tax29922421616512217822684.1114135
Net income513505665577506844941325466587
EBITDA9128681,0098907751,1731,360614766898
EPS, basic3.603.594.784.213.746.377.482.743.894.88
EPS, diluted3.593.574.734.193.726.317.402.723.864.83
Shares, basic (weighted)143141139137136132126119120120
Shares, diluted (weighted)143141140138136134127120121122
Dividend per share1.741.811.882.012.042.082.262.442.462.49

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents248334379448244257217146146161
Receivables1,7112,1142,1621,9742,4503,9632,9922,3822,3842,361
Other current assets49.263.152.48551.2130122163102120
Total current assets2,0082,5112,7532,6402,9424,8043,5892,8812,9702,799
Property, plant and equipment233230228208179140159145127116
Lease right-of-use assets311320293372354335278
Goodwill1,2331,2761,2591,2921,4871,4851,4711,4741,4291,458
Intangible assets16815210990.911489.66443.728.218.2
Other non-current assets44.160.368.385.584.192.311711410895.5
Total assets3,6884,2364,4274,6415,1447,0285,9555,2255,2985,058
Accounts payable8401,0009719851,1951,8131,4671,3041,1781,210
Accrued liabilities98.1105154113138201243135181189
Short-term debt740715514305251,0541604560
Total current liabilities1,8461,9871,4331,5561,8403,3263,3232,0522,3251,832
Long-term debt7501,3411,0921,0931,3949201,4209221,089
Lease liabilities259269241314298291234
Other non-current liabilities0.220.60.430.2714.50.321.932.072.441.43
Total liabilities2,4302,8102,8322,9703,2645,0064,6013,8073,5763,213
Total debt5001,4651,3461,2351,0931,9191,9741,5801,3781,089
Paid-in capital419444521547566674743754775734
Retained earnings3,1913,4373,8464,1454,3734,9375,5905,6215,7866,071
Treasury stock-2,305-2,451-2,714-2,958-3,026-3,540-4,903-4,887-4,741-4,894
Other comprehensive income-61.4-18.5-71.9-76.1-46-61.1-88.9-80.9-110-77.7
Shareholders' equity1,2581,4261,5951,6711,8802,0221,3531,4191,7221,846
Total equity1,2581,4261,5951,6711,8802,0221,3531,4191,7221,846
Total liabilities and equity3,6884,2364,4274,6415,1447,0285,9555,2255,2985,058
Shares outstanding141140137135134129116117119118

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income513505665577506844941325466587
Depreciation and amortization74.79396.710010291.392.89997.2103
Stock-based compensation37.641.887.839.14413090.758.284.680.1
Deferred income tax15-28.1-15.3-2.41-37.9-110-57.6-37.5-78.38
Change in receivables-173-364-190208-452-1,548924607-16495.4
Change in payables11614436.1-18180660-307-201-79.910.8
Cash from operations529384793835499951,650732509915
Capital expenditures-73.5-40.1-45-36.3-23.1-34.2-61.9-30-22.7-19.6
Acquisitions-220-49.1-5.32-59.2-223-14.8000-11.9
Cash from investing-313-108-72.8-113-272-85.7-64.9-82.8-74.3-54.7
Debt issued02505911,2980300200010949
Debt repaid00-1,5050-2.0500-10-1,211
Share buybacks-173-185-301-309-178-582-1,460-63.90-355
Dividends paid-245-258-265-278-210-277-285-292-295-301
Cash from financing-127-202-655-651-4417.57-1,620-718-416-863
Exchange rate effect-9.6811.9-20.2-1.899.13-3.24-5.64-3.28-8.157.23
Net change in cash79.486.244.769.2-20413.6-39.9-7210.54.33
Free cash flow45634474879947660.81,588702486895
Interest paid28.937.947.550.947.551.471.692.686.163.2
Income taxes paid26926321621993.122742915613295

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $147.10 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Operating margin4.9%Operating income / revenue.
EBITDA margin5.5%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin4.6%Pre-tax income / revenue.
Net margin3.7%Net income / revenue.
FCF margin3.9%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin4.0%Cash from operations / revenue.
Effective tax rate18.4%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)38.9%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)10.8%Net income / average total assets.
Return on invested capital (ROIC)21.5%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue0.5%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.1%Capital expenditures / revenue.
D&A / revenue0.6%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-8.4%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-13.1%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y0.0%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y18.8%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y-14.4%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y3.4%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y17.2%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y-12.9%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y3.0%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y26.1%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y-14.5%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y3.0%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y25.1%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y-13.3%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y5.4%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y79.6%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y-17.9%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y12.9%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y84.0%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y-17.4%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y13.5%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y1.2%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y3.3%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y4.1%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y7.2%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y10.9%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-0.4%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-4.5%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-5.3%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-0.3%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y0.7%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-1.5%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-2.3%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.58xCurrent assets / current liabilities.
Quick ratio1.43x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.07x(Cash + short-term investments) / current liabilities.
Debt / equity1.04xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets28.8%Total debt / total assets.
Liabilities / assets72.1%Total liabilities / total assets.
Net debt$1.53BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA1.64xNet debt / EBITDA (twelve months), when EBITDA is positive.
Working capital$1.31BCurrent assets - current liabilities.
Goodwill and intangibles / assets26.5%(Goodwill + intangible assets) / total assets.
Tangible book value$80.6MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover2.91xRevenue / average total assets.
Fixed asset turnover157xRevenue / average property, plant and equipment.
Receivables turnover5.56xRevenue / average receivables.
Days sales outstanding66 days365 x average receivables / revenue.
FCF conversion105.6%Free cash flow / net income, when net income is positive.
Capex / operating cash flow2.4%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$5.29Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$141.93Revenue / diluted weighted shares.
FCF per share$5.58Free cash flow / diluted weighted shares.
Operating cash flow per share$5.72Cash from operations / diluted weighted shares.
Book value per share$13.90Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$0.69Tangible book value / shares outstanding.
Cash per share$1.32(Cash + short-term investments) / shares outstanding.
Payout ratio47.9%Dividends paid / net income, when net income is positive.
Dividends / FCF45.4%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF98.4%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$17.19BShare price x shares outstanding.
Enterprise value$18.72BMarket cap + total debt - cash - short-term investments.
P/E27.1xMarket cap / net income. Only when net income is positive.
P/S1.01xMarket cap / revenue.
P/B10.6xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book213xMarket cap / tangible book value, when positive.
P/FCF25.7xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF25.1xMarket cap / cash from operations, when positive.
EV/Sales1.10xEnterprise value / revenue.
EV/EBIT22.5xEnterprise value / operating income, when both are positive.
EV/EBITDA20.1xEnterprise value / EBITDA, when both are positive.
EV/FCF28.0xEnterprise value / free cash flow, when both are positive.
FCF yield3.9%Free cash flow / market cap.
Earnings yield3.7%Net income / market cap (the inverse of P/E).
Dividend yield1.8%Dividends paid over the period / market cap.
Shareholder yield5.6%(Dividends paid + share buybacks) / market cap.
What was C. H. ROBINSON WORLDWIDE, INC.'s revenue in fiscal 2025?

C. H. ROBINSON WORLDWIDE, INC. reported revenue of $16.23B for fiscal 2025, 8.4% lower than the year before.

Was C. H. ROBINSON WORLDWIDE, INC. profitable in fiscal 2025?

Yes. Net income was $587.1M, a net margin of 3.6%.

How much free cash flow did C. H. ROBINSON WORLDWIDE, INC. generate in fiscal 2025?

Cash from operations of $914.5M minus capital expenditures of $19.6M left free cash flow of $894.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to C. H. ROBINSON WORLDWIDE, INC.